See also this year's filing and all EDGAR filings for this company.
PDF Report 0000078003_2024_Pfizer_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 6.585479256080115, 'aggregate_val': 63627000000, 'exp_sum': 8388000000, 'exp_to_value': {'remainder_Revenues': 8388000000}} |
Graph
Absolute values for 0000078003, Pfizer INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,333,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 132,683,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 18,940,000,000 |
| 3 | remainder_Assets | 31,545,000,000 |
| 4 | LiabilitiesCurrent | 47,794,000,000 |
| 5 | LiabilitiesNoncurrent | 78,077,000,000 |
| 6 | remainder_Liabilities | 11,342,000,000 |
| 7 | CostOfGoodsAndServicesSold | 23,980,158,326 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,217,069,421 |
| 9 | ResearchAndDevelopmentExpense | 10,691,897,119 |
| 10 | remainder_Expenses | 6,183,555,185 |
| 11 | remainder_Revenues | 53,419,258,254 |
| 12 | remainder_NetIncome | 558,400,521 |
| 13 | remainder_ComprehensiveNetIncome | -982,177,859 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 226,501,000,000 |
| 1 | Liabilities | 137,213,000,000 |
| 2 | Expenses | 56,072,680,051 |
| 3 | Revenues | 53,419,258,254 |
| 4 | StockholdersEquity | 89,288,000,000 |
| 5 | NetIncome | -2,095,021,276 |
| 6 | ComprehensiveNetIncome | -2,586,110,206 |
| 7 | BaseVar | 237,373,258,342 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.06 |
| 9 | EconomicCapitalRatio | 2.35 |
Edgar->Model Mapping
Feature Distribution
Change over Time
